These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 35582875)
1. Randomized clinical trial: Direct-acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collection. Beer L; Inglis S; Malaguti A; Byrne C; Sharkey C; Robinson E; Gillings K; Radley A; Hapca A; Stephens B; Dillon J J Viral Hepat; 2022 Aug; 29(8):646-653. PubMed ID: 35582875 [TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol study. Inglis SK; Beer LJ; Byrne C; Malaguti A; Robinson E; Sharkey C; Gillings K; Stephens B; Dillon JF BMJ Open; 2019 Aug; 9(8):e029516. PubMed ID: 31399460 [TBL] [Abstract][Full Text] [Related]
3. Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world data. Palmateer NE; McAuley A; Dillon JF; McDonald S; Yeung A; Smith S; Barclay S; Hayes P; Shepherd SJ; Gunson RN; Goldberg DJ; Hickman M; Hutchinson SJ Addiction; 2021 Oct; 116(10):2893-2907. PubMed ID: 33651446 [TBL] [Abstract][Full Text] [Related]
4. Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. Macías J; Morano LE; Téllez F; Granados R; Rivero-Juárez A; Palacios R; Ríos M; Merino D; Pérez-Pérez M; Collado A; Figueruela B; Morano A; Freyre-Carrillo C; Martín JM; Rivero A; García F; Pineda JA; J Hepatol; 2019 Jul; 71(1):45-51. PubMed ID: 30853642 [TBL] [Abstract][Full Text] [Related]
5. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada. Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB; Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989 [TBL] [Abstract][Full Text] [Related]
6. Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol. Klaman SL; Godino JG; Northrup A; Lewis SV; Tam A; Carrillo C; Lewis R; Matthews E; Mendez B; Reyes L; Rojas S; Ramers C BMC Infect Dis; 2024 Jan; 24(1):105. PubMed ID: 38238686 [TBL] [Abstract][Full Text] [Related]
7. Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya. Akiyama MJ; Riback LR; Nyakowa M; Musyoki H; Lizcano JA; Muller A; Zhang C; Walker JG; Stone J; Vickerman P; Cherutich P; Kurth AE Int J Drug Policy; 2023 Mar; 113():103959. PubMed ID: 36758335 [TBL] [Abstract][Full Text] [Related]
8. Improved health-related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable. McDonald SA; Myring G; Palmateer NE; McAuley A; Beer L; Dillon JF; Hollingworth W; Gunson R; Hickman M; Hutchinson SJ Addiction; 2023 Jul; 118(7):1340-1350. PubMed ID: 36808787 [TBL] [Abstract][Full Text] [Related]
9. Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial. Akiyama MJ; Norton BL; Arnsten JH; Agyemang L; Heo M; Litwin AH Ann Intern Med; 2019 May; 170(9):594-603. PubMed ID: 30959528 [TBL] [Abstract][Full Text] [Related]
10. Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting. Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I Int J Drug Policy; 2017 Sep; 47():209-215. PubMed ID: 28587943 [TBL] [Abstract][Full Text] [Related]
12. Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection. Read P; Gilliver R; Kearley J; Lothian R; Cunningham EB; Chronister KJ; Dore GJ J Viral Hepat; 2019 Nov; 26(11):1301-1310. PubMed ID: 31299127 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients. Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493 [TBL] [Abstract][Full Text] [Related]
14. Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study. Heo M; Norton BL; Pericot-Valverde I; Mehta SH; Tsui JI; Taylor LE; Lum PJ; Feinberg J; Kim AY; Arnsten JH; Sprecht-Walsh S; Page K; Murray-Krezan C; Anderson J; Litwin AH; J Hepatol; 2024 May; 80(5):702-713. PubMed ID: 38242324 [TBL] [Abstract][Full Text] [Related]
15. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol). Hickman M; Dillon JF; Elliott L; De Angelis D; Vickerman P; Foster G; Donnan P; Eriksen A; Flowers P; Goldberg D; Hollingworth W; Ijaz S; Liddell D; Mandal S; Martin N; Beer LJZ; Drysdale K; Fraser H; Glass R; Graham L; Gunson RN; Hamilton E; Harris H; Harris M; Harris R; Heinsbroek E; Hope V; Horwood J; Inglis SK; Innes H; Lane A; Meadows J; McAuley A; Metcalfe C; Migchelsen S; Murray A; Myring G; Palmateer NE; Presanis A; Radley A; Ramsay M; Samartsidis P; Simmons R; Sinka K; Vojt G; Ward Z; Whiteley D; Yeung A; Hutchinson SJ BMJ Open; 2019 Sep; 9(9):e029538. PubMed ID: 31551376 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs. Wade AJ; Doyle JS; Gane E; Stedman C; Draper B; Iser D; Roberts SK; Kemp W; Petrie D; Scott N; Higgs P; Agius PA; Roney J; Stothers L; Thompson AJ; Hellard ME Clin Infect Dis; 2020 Apr; 70(9):1900-1906. PubMed ID: 31233117 [TBL] [Abstract][Full Text] [Related]
17. Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study. Coupland H; Henderson C; Pritchard-Jones J; Kao SC; Sheils S; Nagy R; O'Donnell M; Haber PS; Day CA Harm Reduct J; 2022 May; 19(1):56. PubMed ID: 35643528 [TBL] [Abstract][Full Text] [Related]
18. Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs. E Williams B; Nelons D; Seaman A; Witkowska M; Ronan W; Wheelock H; Zaman A; Garcia J Int J Drug Policy; 2019 Oct; 72():138-145. PubMed ID: 30995968 [TBL] [Abstract][Full Text] [Related]
19. Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs. Midgard H; Finbråten AK; Malme KB; Berg-Pedersen RM; Tanum L; Olsen IC; Bjørnestad R; Dalgard O Trials; 2020 Jun; 21(1):524. PubMed ID: 32539853 [TBL] [Abstract][Full Text] [Related]
20. A transient positive association between direct-acting antiviral therapy for hepatitis C infection and drug-related hospitalization among people who inject drugs: Self-controlled case-series analysis of national data. McDonald SA; Hickman M; Dillon JF; Yeung A; McAuley A; Fraser A; Hayes PC; Hutchinson SJ Addiction; 2024 Feb; 119(2):369-378. PubMed ID: 37726951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]